DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lexapro (Escitalopram) - Completed Suicide - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Completed Suicide ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lexapro (Escitalopram) where reactions include completed suicide. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Lexapro side effects in 21 year old male

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: 21 year old male, weighing 93.0 kg (204.6 pounds)

Reactions: Paranoia, Completed Suicide, GUN Shot Wound

Drug(s) suspected as cause:
Lexapro
    Dosage: 10 mg
    Administration route: Oral
    Indication: Anxiety
    Start date: 2009-06-26
    End date: 2011-10-13

Lexapro
    Dosage: 10 mg
    Administration route: Oral
    Indication: Social Fear
    Start date: 2009-06-26
    End date: 2011-10-13



Possible Lexapro side effects in female

Reported by a physician from Netherlands on 2012-03-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Death, Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Seroquel
    Administration route: Oral
    Indication: Mental Disorder
    Start date: 2012-01-04

Lexapro
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-04



Possible Lexapro side effects in 32 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: 32 year old male

Reactions: Completed Suicide, Toxicity To Various Agents

Adverse event resulted in: death

Drug(s) suspected as cause:
Lexapro
    Indication: Product Used FOR Unknown Indication

Dilantin
    Indication: Product Used FOR Unknown Indication

Seroquel
    Indication: Product Used FOR Unknown Indication

Benadryl
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Dosage: 10 mg (10 mg, 1 in 1 d),
    Indication: Product Used FOR Unknown Indication

Zyprexa
    Indication: Product Used FOR Unknown Indication

Trazodone HCL
    Indication: Product Used FOR Unknown Indication



Possible Lexapro side effects in 32 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-10

Patient: 32 year old male

Reactions: Completed Suicide, Toxicity To Various Agents

Adverse event resulted in: death

Drug(s) suspected as cause:
Benadryl

Seroquel

Zyprexa
    Dosage: 10 mg, 1x/day

Trazodone HCL

Citalopram

Lexapro

Dilantin



Possible Lexapro side effects in 44 year old male

Reported by a lawyer from United States on 2011-10-14

Patient: 44 year old male

Reactions: Agitation, Anxiety, Completed Suicide, Suicidal Ideation

Adverse event resulted in: death

Drug(s) suspected as cause:
Lexapro



Possible Lexapro side effects in 7 year old male

Reported by a physician from United States on 2011-10-06

Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)

Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Aggression
    Start date: 2009-03-18
    End date: 2009-04-16

Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Impulsive Behaviour
    Start date: 2009-03-18
    End date: 2009-04-16

Lexapro
    Dosage: 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2009-02-03
    End date: 2009-03-18

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014